21 to 30 of 35 Results
May 6, 2024 -
Cytosolic Ribosomal Protein Haploinsufficiency affects Mitochondrial Morphology and Respiration
Tabular Data - 11.1 KB - 7 Variables, 97 Observations - UNF:6:o0TrOGF6Ko8yYC/Qr21lRA==
The normalized MitoTracker intensitywere
evaluated in wild type and two [rps-10(0) to wildtype] rescued strains (rescue-1, rescue-2). |
May 6, 2024 -
Cytosolic Ribosomal Protein Haploinsufficiency affects Mitochondrial Morphology and Respiration
Tabular Data - 693 B - 3 Variables, 18 Observations - UNF:6:eDC3woCGPIYnEC36wYrXlw==
normalized oxygen consumption were
evaluated in wild type and two [rps-10(0) to wildtype] rescued strains (rescue-1, rescue-2). ( |
May 6, 2024 -
Cytosolic Ribosomal Protein Haploinsufficiency affects Mitochondrial Morphology and Respiration
Tabular Data - 2.7 KB - 5 Variables, 34 Observations - UNF:6:TRJAj9U/jt8PjgdPiwToYg==
The relative intensity of TOMM-20::TagRFP and COX-4::GFP levels in rps-10 (0)/+ mutants
were quantified and plotted against stage-matched wild-type controls |
May 6, 2024 -
Cytosolic Ribosomal Protein Haploinsufficiency affects Mitochondrial Morphology and Respiration
Tabular Data - 661 B - 3 Variables, 15 Observations - UNF:6:GXw+b6yILvpJjMV5MGeXVQ==
Normalized oxygen consumption rates were plotted for gcn-1(n4827) mutants and gcn-1
RNAi compared to their controls (wild type and non-target RNAi) (left). The effects of rps-10 and
rps-23 RNAi in a wild-type background (middle), alongside the rps-10 and gas-1 RNAi effects in
gcn... |
May 6, 2024 -
Cytosolic Ribosomal Protein Haploinsufficiency affects Mitochondrial Morphology and Respiration
Tabular Data - 594 B - 3 Variables, 15 Observations - UNF:6:dVhy61mTHgrCUtZPQQXcsA==
Normalized oxygen consumption rates were plotted for gcn-1(n4827) mutants and gcn-1
RNAi compared to their controls (wild type and non-target RNAi) (left). The effects of rps-10 and
rps-23 RNAi in a wild-type background (middle), alongside the rps-10 and gas-1 RNAi effects in
gcn... |
May 6, 2024 -
Cytosolic Ribosomal Protein Haploinsufficiency affects Mitochondrial Morphology and Respiration
Tabular Data - 627 B - 3 Variables, 15 Observations - UNF:6:ELcudnuTHSOv+bKXf94IDw==
Normalized oxygen consumption rates were plotted for gcn-1(n4827) mutants and gcn-1
RNAi compared to their controls (wild type and non-target RNAi) (left). The effects of rps-10 and
rps-23 RNAi in a wild-type background (middle), alongside the rps-10 and gas-1 RNAi effects in
gcn... |
May 6, 2024 -
Cytosolic Ribosomal Protein Haploinsufficiency affects Mitochondrial Morphology and Respiration
Tabular Data - 7.6 KB - 5 Variables, 105 Observations - UNF:6:bXQsTXwRAgUMvtPJFAQqaA==
Normalized MitoTracker intensities in response to approximately 50% reduction of RPS10,
RPL35A, RPL5, and RPS23 transcripts were plotted in comparison to nontarget siRNA, where
mitotracker intensity was quantified for at least 100 cells in three biological replicates, and RNA
lev... |
May 6, 2024 -
Cytosolic Ribosomal Protein Haploinsufficiency affects Mitochondrial Morphology and Respiration
Tabular Data - 6.1 KB - 14 Variables, 90 Observations - UNF:6:qc6UeGy58rJHTSpkbsnBsQ==
ADP/ATP ratios in response to approximately 50% knockdown of RPS10, RPL35A, RPL5,
and RPS23 transcripts were plotted in comparison to non-target siRNA. |
May 6, 2024 -
Cytosolic Ribosomal Protein Haploinsufficiency affects Mitochondrial Morphology and Respiration
Tabular Data - 6.9 KB - 20 Variables, 55 Observations - UNF:6:Ut4Ns9IcLuHVy6BxiJVVkw==
) The lifespan of small subunit RP mutants (top) and large subunit mutants (bottom) were
plotted along with their respective controls in the presence of FuDR (5-fluorodeoxyuridine). The
Y-axis represents percent survival and “n” represents the total number of animals. |
May 6, 2024 -
Cytosolic Ribosomal Protein Haploinsufficiency affects Mitochondrial Morphology and Respiration
Tabular Data - 1.1 KB - 5 Variables, 36 Observations - UNF:6:rkBOf7va/pBAvDsSIYZbzA==
(A) Survival fractions were analyzed within 8 hours of oxidative stress after pretreatment of
rapamycin, bortezomib, and cycloheximide in wild-type animals and rpl-5(0)/+ mutants.
(B) Wild-type animals were pretreated with double combinations of rapamycin, bortezomib, and
cyclohe... |